SCOTTSDALE, Ariz. – (April 16th, 2008) TR BioSurgical, LLC (TR BIO), a veterinary biomaterials company, provides a new business opportunity for biomedical companies wanting to enter animal health. TR BIO’s unique business model and resources allows companies to begin realizing revenue from animal health while capturing data to help support their human medical efforts. TR BIO provides comprehensive expertise to bring new technologies to market.
Dr. Jeff Kellerman, TR BIO’s Vice President of R&D, stated, “This is a synergistic model having benefits for all involved. Our partners recognize several advantages, including additional revenues, data capture, enhanced asset valuation, and the ability to identify new applications for their technology.”
TR BIO’s first product, a medical device called TR Matrix, is an advanced bioscaffold that repairs soft and hard tissues. The company is also in late stage development of a new glaucoma device, TR ClarifEYE. TR BioSurgical, LLC has the clinical, regulatory, and commercial expertise to take an existing biomaterial or device and fully develop it for veterinary applications.
Contact: Dr. Jeff Kellerman TR BioSurgical, LLC (480) 258-7770 jkellerman@trbio.com